Gossamer Bio, Inc. (GOSS) Stock Analysis

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split

Fri, September 11, 2026 at 12:00 PM UTC 4 min read

Gossamer Bio has announced the effectiveness of a 1-for-80 reverse stock split, aimed at increasing the per-share price of its common stock. This move is significant for investors as it may enhance the company's appeal to institutional investors and help meet listing requirements for major exchanges. By consolidating shares, Gossamer Bio seeks to improve its market perception and potentially stabilize its stock performance.

Read full article →

Gossamer Bio Announces 1-for-80 Reverse Stock Split

Wed, September 9, 2026 at 1:00 PM UTC 3 min read

Gossamer Bio has announced a 1-for-80 reverse stock split, which will reduce the number of outstanding shares while increasing the share price proportionally. This move is intended to boost the stock's market value and meet the minimum bid price requirements for continued listing on the Nasdaq. For investors, this action may enhance the stock's appeal and stability, potentially attracting institutional investors and improving liquidity.

Read full article →